Dr. Reddy's Laboratories earned a revenue of about 245 billion Indian rupees in financial year 2023, marking a significant recovery from about 190 billion rupees worth revenue in fiscal year 2021. Dr. Reddy's is one of the biggest Indian multinational pharmaceutical companies based in the southern city of Hyderabad.
Revenue of Dr. Reddy's Laboratories Limited from financial year 2014 to 2023 (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
9
- Basic Statistic Top drugs based on projected 2024 global sales
- Basic Statistic Sales of pharmaceuticals in Norway by ATC main group 2021
- Basic Statistic Cardiovascular system pharmaceutical consumption in Belgium 2008-2021
- Basic Statistic Antihypertensive pharmaceutical consumption in Hungary 2007-2022
- Premium Statistic Mexico: pharmaceutical production 2017-2022
- Premium Statistic Top indications for new indication approvals in Canada 2018
- Basic Statistic Antihypertensive pharmaceutical consumption in Austria 2010-2017
- Basic Statistic Cardiovascular system daily pharmaceutical consumption in Iceland 2009-2022
- Basic Statistic Cardiovascular system pharmaceutical consumption in Netherlands 2009-2021
Related statistics
10
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Indian pharmaceutical export value FY 2012-2024
- Premium Statistic Indian pharmaceutical export share FY 2020, by region
- Premium Statistic Alembic Pharma India revenue 2022, by leading therapy drug
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
Further related statistics
10
- Number of patients with non-communicable diseases in India 2010
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Pfizer's ad spending 2006-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Per capita consumer spending in India 1974-2012
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
Further Content: You might find this interesting as well
Statistics
- Number of patients with non-communicable diseases in India 2010
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Pfizer's ad spending 2006-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Per capita consumer spending in India 1974-2012
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
Dr. Reddy's Laboratories. (July 1, 2023). Revenue of Dr. Reddy's Laboratories Limited from financial year 2014 to 2023 (in billion Indian rupees) [Graph]. In Statista. Retrieved April 19, 2024, from https://www.statista.com/statistics/990859/india-drreddy-s-laboratories-revenue/
Dr. Reddy's Laboratories. "Revenue of Dr. Reddy's Laboratories Limited from financial year 2014 to 2023 (in billion Indian rupees)." Chart. July 1, 2023. Statista. Accessed April 19, 2024. https://www.statista.com/statistics/990859/india-drreddy-s-laboratories-revenue/
Dr. Reddy's Laboratories. (2023). Revenue of Dr. Reddy's Laboratories Limited from financial year 2014 to 2023 (in billion Indian rupees). Statista. Statista Inc.. Accessed: April 19, 2024. https://www.statista.com/statistics/990859/india-drreddy-s-laboratories-revenue/
Dr. Reddy's Laboratories. "Revenue of Dr. Reddy's Laboratories Limited from Financial Year 2014 to 2023 (in Billion Indian Rupees)." Statista, Statista Inc., 1 Jul 2023, https://www.statista.com/statistics/990859/india-drreddy-s-laboratories-revenue/
Dr. Reddy's Laboratories, Revenue of Dr. Reddy's Laboratories Limited from financial year 2014 to 2023 (in billion Indian rupees) Statista, https://www.statista.com/statistics/990859/india-drreddy-s-laboratories-revenue/ (last visited April 19, 2024)
Revenue of Dr. Reddy's Laboratories Limited from financial year 2014 to 2023 (in billion Indian rupees) [Graph], Dr. Reddy's Laboratories, July 1, 2023. [Online]. Available: https://www.statista.com/statistics/990859/india-drreddy-s-laboratories-revenue/